Keyphrases
Prison
100%
Wales
95%
Tuberculosis
68%
United Kingdom
58%
HIV Infection
34%
Northern Ireland
30%
Healthcare Workers
30%
Migrants
30%
Public Health
29%
COVID-19
29%
Risk Factors
28%
People in Prison
27%
Vaccination
27%
Confidence Interval
26%
Health Protection
25%
Europe
25%
Prison Environment
24%
HIV-1 Infection
23%
Men Who Have Sex with Men
22%
Contact Tracing
22%
HIV Transmission
21%
Epidemiology
20%
Pre-exposure Prophylaxis (PrEP)
19%
COVID-19 Pandemic
19%
Scoping Review
18%
Infectious Diseases
18%
Human Immunodeficiency Virus Type 1 (HIV-1)
18%
Ethnic Groups
18%
Seroprevalence
18%
Vaccine Uptake
18%
AIDS/HIV
17%
Decontamination
17%
Surveillance Data
16%
Prison Population
16%
Infection Rate
16%
Antiretroviral Therapy
16%
Surveillance System
16%
Whole Genome Sequencing
15%
Meta-analysis
15%
SARS-CoV-2 Infection
15%
Active Tuberculosis
15%
Low-incidence Country
14%
HIV Incidence
14%
Multidrug-resistant Tuberculosis (MDR-TB)
14%
Age Groups
14%
Systematic Meta-analysis
14%
Prison Health
13%
Incarceration
13%
Nosocomial Transmission
13%
Heterosexual
13%
Unlinked
13%
High-income Countries
13%
HIV Patients
13%
Health Care Services
13%
Tuberculosis Incidence
13%
Electronic Library
13%
Population-based Cohort Study
13%
Simulant
13%
Health Systems
13%
Public Health Response
12%
Adjusted Odds Ratio
12%
Influenza
12%
High Incidence
11%
Mycobacterium Tuberculosis (M. tb)
11%
Well-being
11%
Travellers
11%
Measles
10%
Lessons Learned
10%
Tuberculosis Transmission
10%
Invasive Pneumococcal Disease
10%
Infection Control
10%
Injecting Drug Users
10%
Intercourse
10%
Outbreak Investigation
10%
Vaccination Program
10%
Cost-effectiveness
10%
Reinfection
10%
Chemical Injury
10%
World Health Organization
10%
PubMed
9%
Healthcare
9%
HIV Epidemic
9%
COVID-19 Vaccine
9%
Tuberculosis Patients
9%
COVID-19 Impact
9%
Prison Staff
9%
Hepatitis B
9%
Tuberculosis Surveillance
9%
Refugees
9%
Bisexual Men
9%
Clinical Outcomes
9%
Health Equity
9%
Laboratory Confirmation
9%
Infection Prevention
9%
Hepatitis C Virus
9%
Sexually Transmitted Infections
9%
Latent Tuberculosis Infection
8%
Embase
8%
Public Health Risk
8%
Salmonella Enteritidis (S. Enteritidis)
8%
Medicine and Dentistry
Public Health
94%
Infection
83%
Human Immunodeficiency Virus
67%
COVID-19
58%
Diseases
53%
Severe Acute Respiratory Syndrome Coronavirus 2
37%
Systematic Review
31%
Cohort Analysis
28%
Prevalence
25%
Cohort Effect
24%
Men Who Have Sex with Men
22%
Human Immunodeficiency Virus Infection
21%
Health Care
20%
Contact Examination
19%
Primary Health Care
18%
Index Case
18%
Health Care Cost
18%
Human Immunodeficiency Virus 1 Infection
17%
Pre-Exposure Prophylaxis
17%
Surveillance System
16%
Hepatitis B Virus
15%
Odds Ratio
14%
Ethnic Group
14%
Pediatrics
14%
Meta-Analysis
13%
Clinician
12%
Infection Control
11%
Pathogen
11%
Case Finding
11%
Latent Tuberculosis
11%
Health Service
10%
Observational Study
10%
Respiratory Disease
10%
Sexually Transmitted Infection
10%
Cost-Effectiveness Analysis
9%
Household
9%
Infectious Disease
9%
Cross Sectional Study
9%
Infection Prevention
9%
Seroprevalence
9%
Tuberculosis Treatment
9%
Mycobacterium Tuberculosis
9%
Communicable Disease Control
9%
Measles
8%
Polonium
8%
Coronavirinae
8%
Cardiology
8%
COVID-19 Vaccine
8%
4 Iodo 2,5 Dimethoxyamphetamine
8%
Wart Virus
8%
Occupational Exposure
8%
Urinary Tract Infection
8%
Social Distancing
7%
Health Survey
7%
Foreign Born
7%
Social Support
7%
Mental Health
7%
Lung Tuberculosis
7%
Radioisotope
7%
Antibiotic Resistance
7%
Lower Respiratory Tract Infection
7%
Whole Genome Sequencing
7%
Multidrug Resistant Tuberculosis
7%
Mortality Rate
6%
Vulnerable Population
6%
Antibody Response
6%
BCG Vaccination
6%
Reinfection
6%
Horizontal Disease Transmission
6%
Pneumococcal Infection
6%
Long-Term Care
5%
Single Drug Dose
5%
Infection Rate
5%
Serotype
5%
Chlamydiae
5%
Antiretroviral Therapy
5%
Medical Research
5%
Drug Resistant Tuberculosis
5%
Hepatitis E
5%
Interferon
5%
COVID-19 Vaccination
5%
Immunoglobulin
5%
Hepatitis C Virus
5%
Health System
5%
Emergency Care
5%
Interferon Gamma Release Assay
5%
HIV Test
5%
Hepatitis B
5%
Uptake Rates
5%
Health Outcomes
5%
Hepatitis E Virus
5%
Cohort Study
5%